SCHEMBL7904650

SCHEMBL7904650

[CH2]C([CH2])CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26981020 0.79 SLC22A6 (0.50)
SCHEMBL35751 0.76
SCHEMBL8681203 0.73
SCHEMBL6365087 0.73
SCHEMBL28428313 0.73
SCHEMBL9321629 0.73
SCHEMBL8679147 0.73
Ammonia Solution, Strong SCHEMBL9321596 0.73
SCHEMBL10416322 0.73
SCHEMBL15789511 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2975023-B1 GUANIDINOBENZOIC ACID ESTER COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2018-05-30 EP disclosed
US-9969709-B2 Guanidinobenzoic acid ester compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-05-15 US disclosed
US-20160031847-A1 GUANIDINOBENZOIC ACID ESTER COMPOUND ASTELLAS PHARMA INC. (JP) 2016-02-04 US disclosed
EP-2975023-A1 GUANIDINOBENZOIC ACID ESTER COMPOUND Astellas Pharma Inc. (JP) 2016-01-20 EP disclosed
EP-0876161-B1 CONTRAST MEDIA NYCOMED SALUTAR INC (US) 2001-11-21 EP disclosed
EP-0876161-A2 CONTRAST MEDIA NYCOMED SALUTAR, INC. (US) 1998-11-11 EP disclosed
WO-1997026921-A2 CONTRAST MEDIA NYCOMED SALUTAR INC. (US) 1997-07-31 WO disclosed